4-Methylbenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic acid

Catalog No. :
ACEAIP075
CAS No. :
685107-38-4
Molecular Formula :
C12H9N3O2
Molecular Weight :
227.22

IUPAC Name:4-methylbenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic acid

4-Methylbenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$53.00Login to see priceIn stockIn stock
250mg97%$75.00Login to see priceIn stockIn stock
1g97%$297.00Login to see priceIn stockInquiry
5g97%$1480.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methylbenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic acid
IUPAC Name4-methylbenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic acid
MDL No.MFCD03617407
Molecular FormulaC12H9N3O2
Molecular Weight227.22
SMILESO=C(C1=C(C)N2C3=CC=CC=C3N=C2N=C1)O
InChI KeySPUWGRXKFQCJJW-UHFFFAOYSA-N
Synonym4-methylbenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic acid;Pyrimido[1,2-a]benzimidazole-3-carboxylic acid, 4-methyl-;13-Methyl-1,8,10-triazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8,10,12-hexaene-12-carboxylic acid
CAS No.685107-38-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEAIP075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEAIP075 route product structure diagram
    ACEAIP075685107-38-4 In Stock
Inquiry

2. ACEAIP075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEAIP075 route product structure diagram
    ACEAIP075685107-38-4 In Stock
Inquiry

Comments (0)